688105 诺唯赞
午间休市 11-06 11:29:58
资讯
新帖
简况
诺唯赞（688105）11月4日主力资金净买入1157.99万元
证券之星 · 11-05 08:30
诺唯赞（688105）11月4日主力资金净买入1157.99万元
股市必读：11月4日诺唯赞发生2笔大宗交易 成交金额1000万元
证券之星 · 11-05 01:37
股市必读：11月4日诺唯赞发生2笔大宗交易 成交金额1000万元
股市必读：诺唯赞（688105）11月3日收盘跌11.15%，主力净流入433.53万元
证券之星 · 11-04 02:53
股市必读：诺唯赞（688105）11月3日收盘跌11.15%，主力净流入433.53万元
【机构调研记录】蜂巢基金调研诺唯赞
证券之星 · 11-03
【机构调研记录】蜂巢基金调研诺唯赞
【机构调研记录】红塔红土调研诺唯赞
证券之星 · 11-03
【机构调研记录】红塔红土调研诺唯赞
【机构调研记录】泓德基金调研诺唯赞、传音控股等5只个股（附名单）
证券之星 · 11-03
【机构调研记录】泓德基金调研诺唯赞、传音控股等5只个股（附名单）
股市必读：诺唯赞（688105）11月2日披露最新机构调研信息
证券之星 · 11-03
股市必读：诺唯赞（688105）11月2日披露最新机构调研信息
公司互动丨这些公司披露在芯片、机器人等方面最新情况
第一财经 · 11-02
公司互动丨这些公司披露在芯片、机器人等方面最新情况
股市必读：10月30日诺唯赞现2笔折价10.76%的大宗交易 合计成交1410.5万元
证券之星 · 11-02
股市必读：10月30日诺唯赞现2笔折价10.76%的大宗交易 合计成交1410.5万元
诺唯赞（688105）10月30日主力资金净买入3783.69万元
证券之星 · 10-31
诺唯赞（688105）10月30日主力资金净买入3783.69万元
10月30日诺唯赞现2笔折价10.76%的大宗交易 合计成交1410.5万元
证券之星 · 10-30
10月30日诺唯赞现2笔折价10.76%的大宗交易 合计成交1410.5万元
股市必读：诺唯赞三季报 - 第三季度单季净利润同比增长280.37%
证券之星 · 10-30
股市必读：诺唯赞三季报 - 第三季度单季净利润同比增长280.37%
诺唯赞(688105.SH)发布前三季度业绩，归母净利润2422万元，同比增长266.15%
智通财经 · 10-28
诺唯赞(688105.SH)发布前三季度业绩，归母净利润2422万元，同比增长266.15%
10月28日诺唯赞现1笔折价10.49%的大宗交易 合计成交812万元
证券之星 · 10-28
10月28日诺唯赞现1笔折价10.49%的大宗交易 合计成交812万元
诺唯赞(688105)9月30日股东户数1.81万户，较上期增加12.92%
证券之星 · 10-28
诺唯赞(688105)9月30日股东户数1.81万户，较上期增加12.92%
诺唯赞（688105）10月27日主力资金净卖出933.53万元
证券之星 · 10-28
诺唯赞（688105）10月27日主力资金净卖出933.53万元
诺唯赞（688105）10月22日主力资金净卖出527.06万元
证券之星 · 10-23
诺唯赞（688105）10月22日主力资金净卖出527.06万元
诺唯赞（688105）10月21日主力资金净买入44.05万元
证券之星 · 10-22
诺唯赞（688105）10月21日主力资金净买入44.05万元
诺唯赞（688105）10月20日主力资金净买入2722.19万元
证券之星 · 10-21
诺唯赞（688105）10月20日主力资金净买入2722.19万元
股市必读：诺唯赞新发布《诺唯赞关于控股股东权益变动触及1%及5%整数倍暨披露简式权益变动报告书的提示性公告》
证券之星 · 10-19
股市必读：诺唯赞新发布《诺唯赞关于控股股东权益变动触及1%及5%整数倍暨披露简式权益变动报告书的提示性公告》
加载更多
公司概况
公司名称：
南京诺唯赞生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-11-15
主营业务：
南京诺唯赞生物科技股份有限公司的主营业务是酶、抗原、抗体等生物制品的研发、生产和销售。公司的主要产品是生物试剂与仪器、POCT诊断试剂和仪器。报告期内，公司新增发明专利申请49项，新获发明专利授权24项；至报告期末累计申请发明专利352项，累计获得发明专利授权159项，累计申请43项PCT国际专利。
发行价格：
55.00
{"stockData":{"symbol":"688105","market":"SH","secType":"STK","nameCN":"诺唯赞","latestPrice":22.44,"timestamp":1793935798000,"preClose":23.9,"halted":0,"volume":10589809,"delay":0,"changeRate":-0.0611,"floatShares":517000000,"shares":517000000,"eps":0.002,"marketStatus":"午间休市","change":-1.46,"latestTime":"11-06 11:29:58","open":22.53,"high":23.53,"low":22,"amount":239000000,"amplitude":0.064,"askPrice":22.44,"askSize":9,"bidPrice":22.42,"bidSize":101,"shortable":0,"etf":0,"ttmEps":0.002,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793941200000},"marketStatusCode":3,"adr":0,"adjPreClose":23.9,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":26.29,"lowLimit":21.51,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":516985064,"isCdr":false,"pbRate":3.41,"roa":"--","peRate":11220,"roe":"0.64%","epsLYR":-0.04,"committee":0.605263,"marketValue":11601000000,"turnoverRate":0.0205,"status":1,"floatMarketCap":11601000000},"requestUrl":"/m/hq/s/688105","defaultTab":"news","newsList":[{"id":"2681097649","title":"诺唯赞（688105）11月4日主力资金净买入1157.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681097649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681097649?lang=zh_cn&edition=full","pubTime":"2026-11-05 08:30","pubTimestamp":1793838654,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月4日收盘，诺唯赞报收于22.17元，上涨8.68%，换手率3.1%，成交量16.03万手，成交额3.35亿元。近5日资金流向一览见下表：诺唯赞融资融券信息显示，融资方面，当日融资买入2797.06万元，融资偿还3369.31万元，融资净偿还572.25万元。诺唯赞主营业务：主要从事酶、抗原、抗体等生物制品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500009890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681069375","title":"股市必读：11月4日诺唯赞发生2笔大宗交易 成交金额1000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681069375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681069375?lang=zh_cn&edition=full","pubTime":"2026-11-05 01:37","pubTimestamp":1793813850,"startTime":"0","endTime":"0","summary":"截至2026年11月4日收盘，诺唯赞报收于22.17元，上涨8.68%，换手率3.1%，成交量16.03万手，成交额3.35亿元。当日关注点交易信息汇总：11月4日主力资金净流入1157.99万元，占总成交额3.46%。大宗交易11月4日诺唯赞发生2笔大宗交易，成交金额1000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500003166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680977923","title":"股市必读：诺唯赞（688105）11月3日收盘跌11.15%，主力净流入433.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680977923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680977923?lang=zh_cn&edition=full","pubTime":"2026-11-04 02:53","pubTimestamp":1793731991,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，诺唯赞报收于20.4元，下跌11.15%，换手率2.85%，成交量14.75万手，成交额3.14亿元。交易信息汇总股价提醒11月3日诺唯赞收盘报20.4元，跌11.15%，当日成交3.14亿元。前10个交易日主力资金累计净流入4609.68万元，股价累计下跌11.15%；融资余额累计减少1009.56万元，融券余量累计减少1股。资金流向11月3日主力资金净流入433.53万元，占总成交额1.38%；游资资金净流入1246.33万元，占总成交额3.97%；散户资金净流出1679.86万元，占总成交额5.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400004365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680944417","title":"【机构调研记录】蜂巢基金调研诺唯赞","url":"https://stock-news.laohu8.com/highlight/detail?id=2680944417","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680944417?lang=zh_cn&edition=full","pubTime":"2026-11-03 08:03","pubTimestamp":1793664214,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月2日披露的机构调研信息，蜂巢基金近期对1家上市公司进行了调研，相关名单如下：1）诺唯赞 调研纪要：2026年8月《检验类医疗服务价格项目立项指南（试行）》落地后，公司D血检产品入院节奏加快，至2026年10月下旬累计完成220余家正式入院。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300010142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680794151","title":"【机构调研记录】红塔红土调研诺唯赞","url":"https://stock-news.laohu8.com/highlight/detail?id=2680794151","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680794151?lang=zh_cn&edition=full","pubTime":"2026-11-03 08:03","pubTimestamp":1793664212,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月2日披露的机构调研信息，红塔红土近期对1家上市公司进行了调研，相关名单如下：1）诺唯赞 调研纪要：2026年8月《检验类医疗服务价格项目立项指南（试行）》落地后，公司D血检产品入院节奏加快，至2026年10月下旬累计完成220余家正式入院。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300010140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680794118","title":"【机构调研记录】泓德基金调研诺唯赞、传音控股等5只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2680794118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680794118?lang=zh_cn&edition=full","pubTime":"2026-11-03 08:03","pubTimestamp":1793664202,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月2日披露的机构调研信息，泓德基金近期对5家上市公司进行了调研，相关名单如下：1）诺唯赞 调研纪要：2026年8月《检验类医疗服务价格项目立项指南（试行）》落地后，公司D血检产品入院节奏加快，至2026年10月下旬累计完成220余家正式入院。公司通过产品调价、优化产品结构等措施进行价格传导，并适当备货存储，毛利率受竞争格局、成本变化等因素影响，未来将动态调整以保持健康水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300010127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0214","BK1193","LU1969619763.USD","SGXZ49509284.SGD","02636","LU2328871848.SGD","688036","SGXZ81163826.USD","BK0216","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680761053","title":"股市必读：诺唯赞（688105）11月2日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2680761053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680761053?lang=zh_cn&edition=full","pubTime":"2026-11-03 01:06","pubTimestamp":1793639174,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘，诺唯赞报收于22.96元，上涨1.68%，换手率2.72%，成交量14.07万手，成交额3.13亿元。机构调研要点：境外业务2026年前三季度收入同比增速约36%，整体毛利率约80%，已跨过盈亏平衡线，有望贡献利润。机构调研要点：GLP-1原料业务聚焦口服生物法司美格鲁肽中间体，客户覆盖国内主要PI厂家，按季度下达长周期订单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300002527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680376309","title":"公司互动丨这些公司披露在芯片、机器人等方面最新情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2680376309","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680376309?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:16","pubTimestamp":1793628994,"startTime":"0","endTime":"0","summary":"公司互动丨这些公司披露在芯片、机器人等方面最新情况","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611023919088992.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611023919088992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688258","LU1997245177.USD","LU1251922891.USD","LU2289578879.USD","LU2495084118.USD","LU1997244956.HKD","LU0509642566.USD","SGXZ49509284.SGD","LU1997245094.SGD","BK0216","LU2039709279.SGD","LU2778985437.USD","06809","LU1880383440.USD","SGXZ81163826.USD","LU1719994722.HKD","LU0327786744.USD","LU0228659784.USD","LU0456842615.SGD","688008","LU0269904917.USD","LU0828238088.HKD","LU2476274308.USD","LU2476274720.SGD","LU0828237510.HKD","LU1770034418.SGD","LU1303224171.USD","LU0572944931.SGD","688766","BK0214","BK0231","LU1880383366.USD","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680207599","title":"股市必读：10月30日诺唯赞现2笔折价10.76%的大宗交易 合计成交1410.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680207599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680207599?lang=zh_cn&edition=full","pubTime":"2026-11-02 02:16","pubTimestamp":1793556974,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘，诺唯赞报收于22.58元，上涨3.01%，换手率3.32%，成交量17.14万手，成交额3.88亿元。当日关注点交易信息汇总：10月30日主力资金净流入3783.69万元，占总成交额9.76%； 交易信息汇总：当日发生2笔折价10.76%的大宗交易，合计成交1410.5万元。大宗交易10月30日诺唯赞发生2笔大宗交易，折价率10.76%，合计成交金额1410.5万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679822646","title":"诺唯赞（688105）10月30日主力资金净买入3783.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679822646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679822646?lang=zh_cn&edition=full","pubTime":"2026-10-31 08:14","pubTimestamp":1793405678,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，诺唯赞报收于22.58元，上涨3.01%，换手率3.32%，成交量17.14万手，成交额3.88亿元。近5日资金流向一览见下表：诺唯赞融资融券信息显示，融资方面，当日融资买入3038.27万元，融资偿还3074.13万元，融资净偿还35.86万元。诺唯赞主营业务：主要从事酶、抗原、抗体等生物制品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100018107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679152872","title":"10月30日诺唯赞现2笔折价10.76%的大宗交易 合计成交1410.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679152872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679152872?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:38","pubTimestamp":1793360323,"startTime":"0","endTime":"0","summary":"证券之星消息，10月30日诺唯赞发生大宗交易，交易数据如下：近三个月该股共发生32笔大宗交易，合计成交8.11万手，折价成交32笔。该股近期无解禁股上市。截至2026年10月30日收盘，诺唯赞(688105)报收于22.58元，上涨3.01%，换手率3.32%，成交量17.14万手，成交额3.88亿元。该股近半年内有股东持股变动，合计净减持856.13万股，股东增减持明细如下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000048426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679258637","title":"股市必读：诺唯赞三季报 - 第三季度单季净利润同比增长280.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679258637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679258637?lang=zh_cn&edition=full","pubTime":"2026-10-30 07:01","pubTimestamp":1793314862,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，诺唯赞报收于21.92元，下跌3.35%，换手率1.83%，成交量9.48万手，成交额2.13亿元。业绩披露要点：诺唯赞2026年前三季度归母净利润2422.17万元，同比上升266.15%。公司公告汇总：诺唯赞将于2026年11月30日13:00-14:00召开2026年第三季度业绩说明会，通过上证路演中心网络文字互动形式举行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000013051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678945144","title":"诺唯赞(688105.SH)发布前三季度业绩，归母净利润2422万元，同比增长266.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678945144","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678945144?lang=zh_cn&edition=full","pubTime":"2026-10-28 23:10","pubTimestamp":1793200238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺唯赞(688105.SH)披露2026年第三季度报告，前三季度公司实现营收11.31亿元，同比增长18.77%，归母净利润2422万元，同比增长266.15%;扣非净利润亏损2981万元;基本每股收益0.05元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514653.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678608469","title":"10月28日诺唯赞现1笔折价10.49%的大宗交易 合计成交812万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678608469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678608469?lang=zh_cn&edition=full","pubTime":"2026-10-28 19:02","pubTimestamp":1793185324,"startTime":"0","endTime":"0","summary":"证券之星消息，10月28日诺唯赞发生大宗交易，交易数据如下：大宗交易成交价格20.3元，相对当日收盘价折价10.49%，成交40万股，成交金额812万元，买方营业部为机构专用，卖方营业部为中国国际金融股份有限公司北京建国门外大街证券营业部。近三个月该股共发生29笔大宗交易，合计成交7.16万手，折价成交29笔。截至2026年10月28日收盘，诺唯赞报收于22.68元，上涨10.47%，换手率2.76%，成交量14.27万手，成交额3.17亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800041949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678463226","title":"诺唯赞(688105)9月30日股东户数1.81万户，较上期增加12.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678463226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678463226?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:33","pubTimestamp":1793183612,"startTime":"0","endTime":"0","summary":"证券之星消息，近日诺唯赞披露，截至2026年9月30日公司股东户数为1.81万户，较8月31日增加2068.0户，增幅为12.92%。在生物制品行业个股中，诺唯赞股东户数低于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.58万户。从股价来看，2026年8月31日至2026年9月30日，诺唯赞区间涨幅为30.52%，在此期间股东户数增加2068.0户，增幅为12.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800040197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678480213","title":"诺唯赞（688105）10月27日主力资金净卖出933.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678480213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678480213?lang=zh_cn&edition=full","pubTime":"2026-10-28 08:45","pubTimestamp":1793148329,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月27日收盘，诺唯赞报收于20.53元，下跌6.17%，换手率1.67%，成交量8.65万手，成交额1.83亿元。近5日资金流向一览见下表：诺唯赞融资融券信息显示，融资方面，当日融资买入1584.88万元，融资偿还1510.22万元，融资净买入74.66万元。诺唯赞主营业务：主要从事酶、抗原、抗体等生物制品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800014226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677791332","title":"诺唯赞（688105）10月22日主力资金净卖出527.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677791332","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677791332?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:36","pubTimestamp":1792715812,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月22日收盘，诺唯赞报收于21.09元，下跌5.47%，换手率1.57%，成交量8.09万手，成交额1.75亿元。近5日资金流向一览见下表：诺唯赞融资融券信息显示，融资方面，当日融资买入1295.39万元，融资偿还2051.07万元，融资净偿还755.68万元。诺唯赞主营业务：主要从事酶、抗原、抗体等生物制品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300008321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677250986","title":"诺唯赞（688105）10月21日主力资金净买入44.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677250986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677250986?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:28","pubTimestamp":1792628932,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月21日收盘，诺唯赞报收于22.31元，下跌3.13%，换手率1.95%，成交量10.06万手，成交额2.28亿元。近5日资金流向一览见下表：诺唯赞融资融券信息显示，融资方面，当日融资买入2733.0万元，融资偿还2017.62万元，融资净买入715.37万元。诺唯赞主营业务：主要从事酶、抗原、抗体等生物制品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200006952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677957610","title":"诺唯赞（688105）10月20日主力资金净买入2722.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677957610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677957610?lang=zh_cn&edition=full","pubTime":"2026-10-21 08:16","pubTimestamp":1792541792,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月20日收盘，诺唯赞报收于23.03元，上涨7.82%，换手率2.86%，成交量14.78万手，成交额3.31亿元。近5日资金流向一览见下表：诺唯赞融资融券信息显示，融资方面，当日融资买入2458.92万元，融资偿还2663.35万元，融资净偿还204.43万元。诺唯赞主营业务：主要从事酶、抗原、抗体等生物制品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100006891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676857325","title":"股市必读：诺唯赞新发布《诺唯赞关于控股股东权益变动触及1%及5%整数倍暨披露简式权益变动报告书的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676857325","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676857325?lang=zh_cn&edition=full","pubTime":"2026-10-19 03:49","pubTimestamp":1792352948,"startTime":"0","endTime":"0","summary":"公司公告汇总诺唯赞关于控股股东权益变动触及1%及5%整数倍暨披露简式权益变动报告书的提示性公告南京诺唯赞生物科技股份有限公司于2026年10月17日发布公告，公司控股股东南京诺唯赞投资管理集团有限公司通过集中竞价交易方式，自2026年7月24日至10月15日累计增持公司股份5,141,078股，增持比例约为公司总股本的0.9944%，累计增持金额1.0317亿元。本次权益变动后，控股股东及其一致行动人合计持股比例由59.01%上升至60.00%，触及1%及5%整数倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900001163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688105","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793939168271,"stockEarnings":[{"period":"1week","weight":0.0903},{"period":"1month","weight":-0.1226},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.5668},{"period":"1year","weight":0.3853},{"period":"ytd","weight":0.5942}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.0703}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京诺唯赞生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"18079人(较上一季度增加12.92%)","perCapita":"28595股","listingDate":"2021-11-15","address":"江苏省南京市栖霞区南京经济技术开发区科创路红枫科技园C1-2栋东段1-6层","registeredCapital":"51698万元","survey":" 南京诺唯赞生物科技股份有限公司的主营业务是酶、抗原、抗体等生物制品的研发、生产和销售。公司的主要产品是生物试剂与仪器、POCT诊断试剂和仪器。报告期内，公司新增发明专利申请49项，新获发明专利授权24项；至报告期末累计申请发明专利352项，累计获得发明专利授权159项，累计申请43项PCT国际专利。","listedPrice":55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺唯赞(688105)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺唯赞(688105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺唯赞,688105,诺唯赞股票,诺唯赞股票老虎,诺唯赞股票老虎国际,诺唯赞行情,诺唯赞股票行情,诺唯赞股价,诺唯赞股市,诺唯赞股票价格,诺唯赞股票交易,诺唯赞股票购买,诺唯赞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺唯赞(688105)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺唯赞(688105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}